Progyny PGNY 深 滬
已收盤 10-10 16:00:00 美东时间
20.10
-0.470
-2.28%
華盛通- 最 高20.66
- 今 開20.53
- 成交量 174.51万股
- 最 低 20.00
- 昨 收 20.57
- 總市值 17.23亿
- 52周最高 26.76
- 市盈率 靜 35.31
- 換手率 0.00%
- 52周最低 13.39
- 委 比 -97.85%
- 總股本 8571.80万
- 歷史最高 68.32
- 量 比 1.17
- 振 幅 3.21%
- 歷史最低 13.29
- 每 手 1
- 風險率 6.83%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Progyny CEO Named World Economic Forum Champion for Women’s Health
Progyny’s CEO, Pete Anevski, has been recognized as a Champion for Women’s Health by the World Economic Forum and the Global Alliance for Women’s Health. As part of this distinguished group, Anevski will collaborate on initiatives to address global women’s health challenges, drive research, and advocate for better health outcomes. Progyny, a leader in women’s health solutions, aims to leverage its expertise to make meaningful impact through these...
10-07 13:30
HealthEquity's Earnings Outlook
HealthEquity (NASDAQ:HQY) will release its quarterly earnings report on Tuesday...
09-01 22:00
A Glimpse Into The Expert Outlook On Progyny Through 5 Analysts
Progyny (NASDAQ:PGNY) underwent analysis by 5 analysts in the last quarter, rev...
08-27 04:01
Canaccord Genuity Maintains Hold on Progyny, Raises Price Target to $23
Canaccord Genuity analyst Richard Close maintains Progyny (NASDAQ:PGNY) with a Hold and raises the price target from $21 to $23.
08-20 21:59
The Analyst Verdict: Progyny In The Eyes Of 4 Experts
In the preceding three months, 4 analysts have released ratings for Progyny (NA...
08-09 05:03
Cantor Fitzgerald Maintains Overweight on Progyny, Raises Price Target to $28
Cantor Fitzgerald analyst Sarah James maintains Progyny (NASDAQ:PGNY) with a Overweight and raises the price target from $26 to $28.
08-08 23:21
Progyny Raises FY2025 Adj EPS Guidance from $1.54-$1.64 to $1.70-$1.78 vs $0.54 Est
Progyny (NASDAQ:PGNY) raises FY2025 Adj EPS guidance from $1.54-$1.64 to $1.70-$1.78 vs $0.54 analyst estimate..
08-08 04:53
Progyny shares are trading lower. The company reported Q2 financial results.
Progyny shares are trading lower. The company reported Q2 financial results.
08-08 04:23
Progyny Q2 Adj. EPS $0.48 Beats $0.16 Estimate, Sales $332.874M Beat $315.439M Estimate
Progyny (NASDAQ:PGNY) reported quarterly earnings of $0.48 per share which beat the analyst consensus estimate of $0.16 by 201.89 percent. This is a 11.63 percent increase over earnings of $0.43 per share from the same
08-08 04:04
Here are the major earnings after the close Thursday
Major earnings expected after the bell on Thursday include: Block (XYZ) Gilead Sciences (GILD) Twilio (TWLO) The Trade Desk (TTD) Main Street Capital Corporation (MAIN) Other earnings slated for rele...
08-07 22:00
